O. W. Hakenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
O. W. Hakenberg has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
M.P. Wirth
3 shared publicationsG Kovacs
2 shared publicationsK Schalkhäuser
2 shared publicationsL Ahlemann
2 shared publicationsM P Wirth
2 shared publicationsM. P. Wirth
Klinik und Poliklinik für Urologie, Technische Universität Dresden, Dresden
2 shared publications
Latest Publications
- 31 March 2007
- Published by Elsevier in European Urology Supplements
- Vol. 6 (2) , 119
387 MULTITARGET SIRNA INHIBITION OF ANTIAPOPTOTIC GENES IN BLADDER CANCER CELLS
- 31 March 2007
- Published by Elsevier in European Urology Supplements
- Vol. 6 (2) , 119
387 MULTITARGET SIRNA INHIBITION OF ANTIAPOPTOTIC GENES IN BLADDER CANCER CELLS
- 30 April 2006
- Published by Elsevier in European Urology Supplements
- Vol. 5 (2) , 292
PERI-OPERATIVE COMPLICATIONS ACCORDING TO COMORBIDITY AND AGE IN PATIENTS AFTER RADICAL CYSTECTOMY
- 30 April 2006
- Published by Elsevier in European Urology Supplements
- Vol. 5 (2) , 292
PERI-OPERATIVE COMPLICATIONS ACCORDING TO COMORBIDITY AND AGE IN PATIENTS AFTER RADICAL CYSTECTOMY
- 6 September 2005
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 130 (36) , 2002-2004
Prävention des Prostatakarzinoms
Prostate cancer has become the most frequently diagnosed male cancer next to non-melanotic skin cancer in the Western world. Preventive measures would therefore have important potential effects on the incidence and prevalence of this disease. A potential for effective prevention of prostate cancer is currently seen in dietary changes and perhaps in dietary supplementation with vitamins D and E or selenium. Pharmacological prevention seems a possibility with drugs acting on intraprostatic testosterone metabolism. Several large randomised trials are ongoing to clarify the potential for successful prostate cancer prevention.
- 6 September 2005
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 130 (36) , 2002-2004
Prävention des Prostatakarzinoms
Prostate cancer has become the most frequently diagnosed male cancer next to non-melanotic skin cancer in the Western world. Preventive measures would therefore have important potential effects on the incidence and prevalence of this disease. A potential for effective prevention of prostate cancer is currently seen in dietary changes and perhaps in dietary supplementation with vitamins D and E or selenium. Pharmacological prevention seems a possibility with drugs acting on intraprostatic testosterone metabolism. Several large randomised trials are ongoing to clarify the potential for successful prostate cancer prevention.
- 1 February 2002
- Vol. 178 (2) , 115-9
[Recommendations for treatment with permanent, interstitial brachytherapy alone in locally limited prostate cancer].
- 1 February 2002
- Vol. 178 (2) , 115-9
[Recommendations for treatment with permanent, interstitial brachytherapy alone in locally limited prostate cancer].
- 1 October 2001
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 32 (06) , 368-371
Ist die systematische Biopsie der Transitionalzone zusätzlich zur Sextantenbiopsie der Prostata sinnvoll?
Einleitung: Ziel war die Untersuchung der Wertigkeit von 4 zusätzlichen Transitionalzonenbiopsien bei Patienten, die sich bei Verdacht auf das Vorliegen eines Prostatakarzinoms einer ultraschallgesteuerten Sextantenbiopsie der Prostata unterzogen. Patienten und Methoden: 324 Patienten mit dem Verdacht auf das Vorliegen eines Prostatakarzinoms (PSA ≥ 4 ng/ml: n = 287; abnormer rektaler Tastbefund: n = 127) wurden prospektiv untersucht. 170 Patienten hatten zuvor bereits eine oder mehrere negative Biopsien. Neben den üblichen Sextantenbiopsien wurden in jedem Seitenlappen 2 zusätzliche Biopsien aus der Transitionalzone entnommen. Ergebnisse: Bei 110/324 Patienten wurde ein Prostatakarzinom nachgewiesen. Bei 10 dieser 110 Patienten waren ausschließlich Biopsien der Transitionalzone positiv, während 32 Patienten ausschließlich in Biopsien der peripheren Zone und 68 Patienten in beiden Zonen Tumorgewebe aufwiesen. Ausschließlich in der Transitionalzone positive Biopsien wurden relativ häufig bei T1c-Tumoren (7/10) und im PSA-Bereich zwischen 4 und 10 ng/ml (7/10) gefunden. Bei Patienten mit vorangegangenen negativen Biopsien waren die gesamte Tumordetektionsrate (32,9 % vs. 35,1 %) und die Detektionsrate von nur in der Transitionalzone nachweisbaren Karzinomen (2,4 % vs. 3,9 %) ähnlich wie bei den nicht vorbiopsierten Patienten. Schlussfolgerung: Eine Entnahme von 4 zusätzlichen Transitionalzonenbiopsien erhöht die Tumordetektionsrate insgesamt nur marginal. Ausschließlich in der Transitionalzone positive Biopsien wurden vorwiegend bei nicht tastbaren Tumoren und im PSA-Bereich zwischen 4 und 10 ng/ml beobachtet. Introduction: The aim of this study was to evaluate the diagnostic value of performing 4 additional transition zone biopsies in patients undergoing routine sextant biopsy of the prostate. Patients and methods: A total of 324 patients with a serum prostate specific antigen (PSA) elevation > 4 ng/ml (n = 287) and/or a suspicious digital rectal examination (n = 127) were evaluated prospectively. Of the 324, 170 patients had already undergone one or more previous sets of negative prostatic biopsies. In all patients, 4 transition zone biopsies were taken in addition to a routine, ultrasound-guided sextant biopsy. Results: Prostate cancer was found in 110 of the 324 patients. Positive biopsies were located in the transition zones of only 10 of these 110 patients, in the peripheral zones in 32 and 68 patients showed cancer in both peripheral and transition zone biopsy cores. Prostate cancers seen exclusively in the transition zones were predominantly non-palpable pT1c tumours (7/10) with PSA values between 4 and 10 ng/ml. Compared to patients without previous biopsies, in those patients with previously negative prostate biopsies the tumour detection rate of this 10-core-biopsy technique was similar both for overall tumour detection (32,9 % vs 35,1 %) as well as for the detection of prostate cancers found exclusively in the transition zones (2,4 % vs 3,9 %). Conclusions: Taking four additional transition zone biospies with a routine sextant prostate biopsy only marginally increases the overall tumour detection rate. It does, however, lead to the detection of a small number of prostate cancers confined to the transition zone, which present with PSA-elevation and negative digital rectal findings.
- 1 October 2001
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 32 (06) , 368-371
Ist die systematische Biopsie der Transitionalzone zusätzlich zur Sextantenbiopsie der Prostata sinnvoll?
Einleitung: Ziel war die Untersuchung der Wertigkeit von 4 zusätzlichen Transitionalzonenbiopsien bei Patienten, die sich bei Verdacht auf das Vorliegen eines Prostatakarzinoms einer ultraschallgesteuerten Sextantenbiopsie der Prostata unterzogen. Patienten und Methoden: 324 Patienten mit dem Verdacht auf das Vorliegen eines Prostatakarzinoms (PSA ≥ 4 ng/ml: n = 287; abnormer rektaler Tastbefund: n = 127) wurden prospektiv untersucht. 170 Patienten hatten zuvor bereits eine oder mehrere negative Biopsien. Neben den üblichen Sextantenbiopsien wurden in jedem Seitenlappen 2 zusätzliche Biopsien aus der Transitionalzone entnommen. Ergebnisse: Bei 110/324 Patienten wurde ein Prostatakarzinom nachgewiesen. Bei 10 dieser 110 Patienten waren ausschließlich Biopsien der Transitionalzone positiv, während 32 Patienten ausschließlich in Biopsien der peripheren Zone und 68 Patienten in beiden Zonen Tumorgewebe aufwiesen. Ausschließlich in der Transitionalzone positive Biopsien wurden relativ häufig bei T1c-Tumoren (7/10) und im PSA-Bereich zwischen 4 und 10 ng/ml (7/10) gefunden. Bei Patienten mit vorangegangenen negativen Biopsien waren die gesamte Tumordetektionsrate (32,9 % vs. 35,1 %) und die Detektionsrate von nur in der Transitionalzone nachweisbaren Karzinomen (2,4 % vs. 3,9 %) ähnlich wie bei den nicht vorbiopsierten Patienten. Schlussfolgerung: Eine Entnahme von 4 zusätzlichen Transitionalzonenbiopsien erhöht die Tumordetektionsrate insgesamt nur marginal. Ausschließlich in der Transitionalzone positive Biopsien wurden vorwiegend bei nicht tastbaren Tumoren und im PSA-Bereich zwischen 4 und 10 ng/ml beobachtet. Introduction: The aim of this study was to evaluate the diagnostic value of performing 4 additional transition zone biopsies in patients undergoing routine sextant biopsy of the prostate. Patients and methods: A total of 324 patients with a serum prostate specific antigen (PSA) elevation > 4 ng/ml (n = 287) and/or a suspicious digital rectal examination (n = 127) were evaluated prospectively. Of the 324, 170 patients had already undergone one or more previous sets of negative prostatic biopsies. In all patients, 4 transition zone biopsies were taken in addition to a routine, ultrasound-guided sextant biopsy. Results: Prostate cancer was found in 110 of the 324 patients. Positive biopsies were located in the transition zones of only 10 of these 110 patients, in the peripheral zones in 32 and 68 patients showed cancer in both peripheral and transition zone biopsy cores. Prostate cancers seen exclusively in the transition zones were predominantly non-palpable pT1c tumours (7/10) with PSA values between 4 and 10 ng/ml. Compared to patients without previous biopsies, in those patients with previously negative prostate biopsies the tumour detection rate of this 10-core-biopsy technique was similar both for overall tumour detection (32,9 % vs 35,1 %) as well as for the detection of prostate cancers found exclusively in the transition zones (2,4 % vs 3,9 %). Conclusions: Taking four additional transition zone biospies with a routine sextant prostate biopsy only marginally increases the overall tumour detection rate. It does, however, lead to the detection of a small number of prostate cancers confined to the transition zone, which present with PSA-elevation and negative digital rectal findings.
- 1 February 2001
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 24 (1) , 48-52
The Treatment of Primary Urethral Carcinoma – the Dilemmas of a Rare Condition: Experience with Partial Urethrectomy and Adjuvant Chemotherapy
Background: Primary urethral carcinoma is a very rare condition, and no large-scale experience with such cases has been published. Treatment will therefore have to follow rules established for the treatment of similar conditions. Patients: Six cases of primary urethral carcinoma (5 male, 1 female) who had been treated at our institution between 1995 and 1999 were retrospectively analyzed. In 3 male cases, a primary urothelial carcinoma of the distal urethra was treated by distal urethrectomy only. In 3 other cases with locally advanced tumors and/or lymph node metastases surgical treatment was followed by adjuvant cisplatinum-containing chemotherapy. Results: In the 3 cases with distal urethral carcinoma, partial urethrectomy with preservation of the penis resulted in cure, with a follow-up of 12–71 months. In the cases with advanced disease, adjuvant chemotherapy after surgery has resulted in complete remissions in all 3 cases, with a follow-up of 4–47 months at present. Conclusions: In localized, noninvasive carcinoma of the distal male urethra, partial urethrectomy seems adequate and the avoidance of penile amputation justified. In advanced cases, after local excision and lymphadenectomy adjuvant chemotherapy which by necessity must follow the guidelines established for the treatment of other urothelial or squamous cell malignancies seems to be beneficial.
- 1 February 2001
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 24 (1) , 48-52
The Treatment of Primary Urethral Carcinoma – the Dilemmas of a Rare Condition: Experience with Partial Urethrectomy and Adjuvant Chemotherapy
Background: Primary urethral carcinoma is a very rare condition, and no large-scale experience with such cases has been published. Treatment will therefore have to follow rules established for the treatment of similar conditions. Patients: Six cases of primary urethral carcinoma (5 male, 1 female) who had been treated at our institution between 1995 and 1999 were retrospectively analyzed. In 3 male cases, a primary urothelial carcinoma of the distal urethra was treated by distal urethrectomy only. In 3 other cases with locally advanced tumors and/or lymph node metastases surgical treatment was followed by adjuvant cisplatinum-containing chemotherapy. Results: In the 3 cases with distal urethral carcinoma, partial urethrectomy with preservation of the penis resulted in cure, with a follow-up of 12–71 months. In the cases with advanced disease, adjuvant chemotherapy after surgery has resulted in complete remissions in all 3 cases, with a follow-up of 4–47 months at present. Conclusions: In localized, noninvasive carcinoma of the distal male urethra, partial urethrectomy seems adequate and the avoidance of penile amputation justified. In advanced cases, after local excision and lymphadenectomy adjuvant chemotherapy which by necessity must follow the guidelines established for the treatment of other urothelial or squamous cell malignancies seems to be beneficial.
- 1 March 2000
- Vol. 163 (3) , 894-5
Ossifying cavernous hemangioma masquerading as adrenal tuberculosis.
- 1 March 2000
- Vol. 163 (3) , 894-5
Ossifying cavernous hemangioma masquerading as adrenal tuberculosis.